These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28717351)

  • 21. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
    Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
    J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
    Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
    Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood biomarkers for traumatic brain injury: A narrative review of current evidence.
    Hossain I; Marklund N; Czeiter E; Hutchinson P; Buki A
    Brain Spine; 2024; 4():102735. PubMed ID: 38510630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Blood Biomarkers for Magnetic Resonance Imaging Diagnosis of Traumatic Brain Injury.
    Yue JK; Upadhyayula PS; Avalos LN; Deng H; Wang KKW
    Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32098419
    [No Abstract]   [Full Text] [Related]  

  • 25. Current Trends in Biomarkers for Traumatic Brain Injury.
    Mehta T; Fayyaz M; Giler GE; Kaur H; Raikwar SP; Kempuraj D; Selvakumar GP; Ahmed ME; Thangavel R; Zaheer S; Iyer S; Govindarajan R; Zaheer A
    Open Access J Neurol Neurosurg; 2020; 12(4):86-94. PubMed ID: 32775958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI.
    Shahim P; Politis A; van der Merwe A; Moore B; Ekanayake V; Lippa SM; Chou YY; Pham DL; Butman JA; Diaz-Arrastia R; Zetterberg H; Blennow K; Gill JM; Brody DL; Chan L
    Neurology; 2020 Aug; 95(6):e623-e636. PubMed ID: 32641529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of early dexmedetomidine exposure with brain injury biomarker levels following moderate - Severe traumatic brain injury: A TRACK-TBI study.
    Wongsripuemtet P; Ohnuma T; Temkin N; Barber J; Komisarow J; Manley GT; Hatfield J; Treggiari M; Colton K; Sasannejad C; Chaikittisilpa N; Ivins-O'Keefe K; Grandhi R; Laskowitz D; Mathew JP; Hernandez A; James ML; Raghunathan K; Miller J; Vavilala M; Krishnamoorthy V;
    J Clin Neurosci; 2024 Jul; 126():338-347. PubMed ID: 39029302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct Serum Glial Fibrillary Acidic Protein and Neurofilament Light Time-Courses After Rapid Head Rotations.
    Huber CM; Thakore AD; Oeur RA; Margulies SS
    J Neurotrauma; 2024 May; ():. PubMed ID: 38698671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.
    Diaz-Arrastia R; Wang KK; Papa L; Sorani MD; Yue JK; Puccio AM; McMahon PJ; Inoue T; Yuh EL; Lingsma HF; Maas AI; Valadka AB; Okonkwo DO; Manley GT;
    J Neurotrauma; 2014 Jan; 31(1):19-25. PubMed ID: 23865516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
    Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
    Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.
    Welch RD; Ellis M; Lewis LM; Ayaz SI; Mika VH; Millis S; Papa L
    J Neurotrauma; 2017 Jun; 34(11):1957-1971. PubMed ID: 28031000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
    Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
    Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raman Spectroscopy Spectral Fingerprints of Biomarkers of Traumatic Brain Injury.
    Harris G; Stickland CA; Lim M; Goldberg Oppenheimer P
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Role of Serum-Based Neuronal and Glial Markers as Potential Predictors for Distinguishing Severity and Related Outcomes in Traumatic Brain Injury.
    Lee JY; Lee CY; Kim HR; Lee CH; Kim HW; Kim JH
    J Korean Neurosurg Soc; 2015 Aug; 58(2):93-100. PubMed ID: 26361523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.
    Mondello S; Papa L; Buki A; Bullock MR; Czeiter E; Tortella FC; Wang KK; Hayes RL
    Crit Care; 2011 Jun; 15(3):R156. PubMed ID: 21702960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers Associated with the Outcome of Traumatic Brain Injury Patients.
    Lorente L
    Brain Sci; 2017 Oct; 7(11):. PubMed ID: 29076989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omega-3 Fatty Acids and Vitamin D Decrease Plasma T-Tau, GFAP, and UCH-L1 in Experimental Traumatic Brain Injury.
    Scrimgeour AG; Condlin ML; Loban A; DeMar JC
    Front Nutr; 2021; 8():685220. PubMed ID: 34150829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
    Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
    EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury.
    Žurek J; Fedora M
    Acta Neurochir (Wien); 2012 Jan; 154(1):93-103; discussion 103. PubMed ID: 21976236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.
    Takala RS; Posti JP; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Hossain MI; Coles JP; Hutchinson P; van Gils M; Menon DK; Tenovuo O
    World Neurosurg; 2016 Mar; 87():8-20. PubMed ID: 26547005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.